CME Group Inc.
BG ˙ BUL ˙ US12572Q1058
SecurityBG:MX4A / CME Group Inc.
InstitutionIntermede Investment Partners Ltd
Latest Disclosed Ownership270,331 shares
Latest Disclosed Value $ 79,842
Intermede Investment Partners Ltd reports 5.13% decrease in ownership of MX4A / CME Group Inc.

On May 15, 2026 - Intermede Investment Partners Ltd filed a 13F-HR form disclosing ownership of 270,331 shares of CME Group Inc. (BG:MX4A) valued at $79,842 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 284,959 shares of CME Group Inc.. This represents a change in shares of -5.13% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CME GROUP COM 12572Q105 270,331 -14,628 -5.13 80 2.60 3.6995
2026-02-09 2025-12-31 13F CME GROUP COM 12572Q105 284,959 284,959 78 3.1975
2025-05-15 2025-03-31 13F CME GROUP COM 12572Q105 0 -556,034 -100.00 0 -100.00
2025-02-10 2024-12-31 13F CME GROUP COM 12572Q105 556,034 -153,697 -21.66 129 -17.31 3.4453
2024-11-04 2024-09-30 13F CME GROUP COM 12572Q105 709,731 -13,639 -1.89 157 9.86 3.2681
2024-07-17 2024-06-30 13F CME GROUP COM 12572Q105 723,370 -48,006 -6.22 142 -14.46 3.0052
2024-05-10 2024-03-31 13F CME GROUP COM 12572Q105 771,376 -246,777 -24.24 166 -22.43 3.3874
2024-02-12 2023-12-31 13F CME GROUP COM 12572Q105 1,018,153 -49,926 -4.67 214 0.47 4.8663
2023-11-08 2023-09-30 13F CME GROUP COM 12572Q105 1,068,079 -42,367 -3.82 214 3.90 5.4786
2023-08-09 2023-06-30 13F CME GROUP COM 12572Q105 1,110,446 -1,156 -0.10 206 -3.30 4.8044
2023-05-15 2023-03-31 13F CME GROUP COM 12572Q105 1,111,602 -110,855 -9.07 213 3.41 5.2154
2023-02-09 2022-12-31 13F CME GROUP COM 12572Q105 1,222,457 104,111 9.31 206 -99.90 5.7413
2022-10-24 2022-09-30 13F CME GROUP COM 12572Q105 1,118,346 82,142 7.93 198,093 -6.61 5.5536
2022-08-03 2022-06-30 13F CME GROUP COM 12572Q105 1,036,204 29,987 2.98 212,111 -11.38 5.8792
2022-04-28 2022-03-31 13F CME GROUP COM 12572Q105 1,006,217 66,208 7.04 239,339 11.45 5.6000
2022-01-14 2021-12-31 13F CME GROUP COM 12572Q105 940,009 -32,874 -3.38 214,754 14.15 4.4208
2021-10-27 2021-09-30 13F CME GROUP COM 12572Q105 972,883 -9,774 -0.99 188,136 -9.98 4.3276
2021-07-30 2021-06-30 13F CME GROUP COM 12572Q105 982,657 46,903 5.01 208,991 9.36 4.7522
2021-05-07 2021-03-31 13F CME GROUP COM 12572Q105 935,754 155,129 19.87 191,109 34.48 4.8835
2021-02-05 2020-12-31 13F CME GROUP COM 12572Q105 780,625 243,181 45.25 142,113 58.04 4.1050
2020-10-29 2020-09-30 13F CME GROUP COM 12572Q105 537,444 20,580 3.98 89,920 7.03 3.7553
2020-08-06 2020-06-30 13F CME GROUP COM 12572Q105 516,864 12,418 2.46 84,011 -3.68 4.1098
2020-05-11 2020-03-31 13F CME GROUP COM 12572Q105 504,446 20,235 4.18 87,224 -10.26 5.1384
2020-02-10 2019-12-31 13F CME GROUP COM 12572Q105 484,211 7,797 1.64 97,191 -3.47 4.9201
2019-11-01 2019-09-30 13F CME GROUP COM 12572Q105 476,414 -5,584 -1.16 100,685 7.61 5.5892
2019-07-30 2019-06-30 13F CME GROUP COM 12572Q105 481,998 -7,306 -1.49 93,561 16.18 5.5389
2019-05-01 2019-03-31 13F CME GROUP COM 12572Q105 489,304 58,754 13.65 80,530 -0.57 5.0069
2019-02-14 2018-12-31 13F CME GROUP COM 12572Q105 430,550 21,506 5.26 80,995 16.33 6.4732
2018-10-29 2018-09-30 13F CME GROUP COM 12572Q105 409,044 16,286 4.15 69,623 8.14 5.2157
2018-08-08 2018-06-30 13F CME GROUP COM 12572Q105 392,758 -13,136 -3.24 64,381 -1.93 5.0929
2018-05-01 2018-03-31 13F CME GROUP COM 12572Q105 405,894 -23,297 -5.43 65,649 4.73 5.6367
2018-01-19 2017-12-31 13F CME GROUP COM 12572Q105 429,191 19,814 4.84 62,683 12.85 5.3255
2017-10-24 2017-09-30 13F CME GROUP COM 12572Q105 409,377 1,009 0.25 55,544 8.60 5.0789
2017-07-17 2017-06-30 13F CME GROUP COM 12572Q105 408,368 74,393 22.28 51,144 28.90 4.9459
2017-04-25 2017-03-31 13F CME GROUP COM 12572Q105 333,975 -24,043 -6.72 39,676 -3.93 4.1454
2017-01-17 2016-12-31 13F CME GROUP COM 12572Q105 358,018 -9,460 -2.57 41,297 7.52 4.8390
2016-10-27 2016-09-30 13F CME GROUP COM 12572Q105 367,478 4,529 1.25 38,409 8.65 4.2506
2016-07-27 2016-06-30 13F CME GROUP COM 12572Q105 362,949 7,286 2.05 35,351 3.48 4.0987
2016-04-14 2016-03-31 13F CME GROUP COM 12572Q105 355,663 103,892 41.26 34,161 49.76 4.1150
2016-02-05 2015-12-31 13F CME GROUP COM 12572Q105 251,771 251,771 22,810 3.8622
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.